PMID- 22491252 OWN - NLM STAT- MEDLINE DCOM- 20120807 LR - 20211021 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 188 IP - 10 DP - 2012 May 15 TI - Usp18 promotes conventional CD11b+ dendritic cell development. PG - 4776-81 LID - 10.4049/jimmunol.1101609 [doi] AB - Dendritic cells (DCs) represent the key cells linking innate and adaptive immune responses. It is critical to understand the molecular factors regulating DC differentiation. Usp18 is an IFN-inducible member of the ubiquitin-specific protease family, which deconjugates ubiquitin-like modifier ISG15 from target proteins and competitively inhibits IFN-alpha/beta-induced JAK/STAT activation. This study demonstrates that the frequency of conventional CD11b(+) DCs in the spleen of Usp18(-/-) mice was significantly reduced, whereas the frequencies of conventional CD8(+) DCs and plasmacytoid DCs remained normal. In addition, Usp18(-/-) bone marrow (BM) cells generate DCs less efficiently in GM-CSF-supplemented culture, demonstrating a fundamental defect throughout the DC differentiation pathway. Usp18(-/-) BM cells were rescued by exogenous expression of either wild-type or deconjugation-inactive Usp18, and superimposition of an IFN-alpha/beta receptor knockout returned in vivo DC populations to normal, clearly showing that the defect seen is due solely to Usp18's effect on IFN signaling. Finally, Usp18(-/-) BM-derived DCs expressed high levels of SOCS1/SOCS3, known inhibitors of GM-CSF signaling, providing a mechanistic explanation for the phenotype. In conclusion, we have identified a novel role of Usp18 in modulating conventional CD11b(+) DC development via its inhibitory effect on type I IFN signaling. FAU - Cong, Xiu-Li AU - Cong XL AD - Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA. FAU - Lo, Miao-Chia AU - Lo MC FAU - Reuter, Brian A AU - Reuter BA FAU - Yan, Ming AU - Yan M FAU - Fan, Jun-Bao AU - Fan JB FAU - Zhang, Dong-Er AU - Zhang DE LA - eng GR - R01 HL091549/HL/NHLBI NIH HHS/United States GR - R01 HL091549-14/HL/NHLBI NIH HHS/United States GR - HL091549/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20120409 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (CD11b Antigen) RN - 0 (CD8 Antigens) RN - 0 (Growth Substances) RN - 0 (Socs1 protein, mouse) RN - 0 (Socs3 protein, mouse) RN - 0 (Suppressor of Cytokine Signaling 1 Protein) RN - 0 (Suppressor of Cytokine Signaling 3 Protein) RN - 0 (Suppressor of Cytokine Signaling Proteins) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) RN - EC 3.4.- (Endopeptidases) RN - EC 3.4.19.- (Usp18 protein, mouse) RN - EC 3.4.19.12 (Ubiquitin Thiolesterase) SB - IM MH - Animals MH - CD11b Antigen/*biosynthesis MH - CD8 Antigens/biosynthesis MH - Cell Count MH - Cell Differentiation/genetics/*immunology MH - Cells, Cultured MH - Dendritic Cells/cytology/enzymology/*immunology MH - Down-Regulation/genetics/immunology MH - Endopeptidases/deficiency/genetics/*physiology MH - Female MH - Granulocyte-Macrophage Colony-Stimulating Factor/antagonists & inhibitors/physiology MH - Growth Substances/deficiency/genetics/physiology MH - Male MH - Mice MH - Mice, Knockout MH - Suppressor of Cytokine Signaling 1 Protein MH - Suppressor of Cytokine Signaling 3 Protein MH - Suppressor of Cytokine Signaling Proteins/biosynthesis/physiology MH - Ubiquitin Thiolesterase PMC - PMC3345079 MID - NIHMS363172 COIS- Conflict-of-interest disclosure The authors declare no competing financial interests EDAT- 2012/04/12 06:00 MHDA- 2012/08/08 06:00 PMCR- 2013/05/15 CRDT- 2012/04/12 06:00 PHST- 2012/04/12 06:00 [entrez] PHST- 2012/04/12 06:00 [pubmed] PHST- 2012/08/08 06:00 [medline] PHST- 2013/05/15 00:00 [pmc-release] AID - jimmunol.1101609 [pii] AID - 10.4049/jimmunol.1101609 [doi] PST - ppublish SO - J Immunol. 2012 May 15;188(10):4776-81. doi: 10.4049/jimmunol.1101609. Epub 2012 Apr 9.